Category Archives: Biologics

U.S. Stem Cell Policy – Ceding the Competitive Edge

By a margin of 63-34, the Senate passed the Stem Cell Research Enhancement Act -  just 3 votes shy of a veto-proof bill.  A veto is promised.  We are back where we started.  Opponents claim a moral high ground that … Continue reading

Posted in Biologics, Current Affairs, Legislation | Comments Off

The Bio Conference and the FDA Survey

The BIO conference was held last week in the wonderful city of Chicago.  A lot of people have been writing about it.  So I decided to join in.  The blog On Pharma has some very nice daily updates.  Former President … Continue reading

Posted in Biologics, FDA Policy | Comments Off